ScholarIQanswers from OpenAlex

Conservative treatment of upper urinary tract carcinoma in patients with imperative indications

PaperCitations, authors & open-access status

Conservative treatment of upper urinary tract carcinoma in patients with imperative indications is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Conservative treatment of upper urinary tract carcinoma in patients with imperative indications have?

ScholarIQcitation count

Conservative treatment of upper urinary tract carcinoma in patients with imperative indications has 22 citations in the OpenAlex counts ScholarIQ stores.

When was Conservative treatment of upper urinary tract carcinoma in patients with imperative indications published?

ScholarIQyear

Conservative treatment of upper urinary tract carcinoma in patients with imperative indications has 2021 year in the ScholarIQ index.

What is the open-access status of Conservative treatment of upper urinary tract carcinoma in patients with imperative indications?

ScholarIQoa status

Conservative treatment of upper urinary tract carcinoma in patients with imperative indications has closed oa status in the ScholarIQ index.

What is the DOI of Conservative treatment of upper urinary tract carcinoma in patients with imperative indications?

ScholarIQdoi

The DOI for Conservative treatment of upper urinary tract carcinoma in patients with imperative indications is on the source record.

What is the PMID of Conservative treatment of upper urinary tract carcinoma in patients with imperative indications?

ScholarIQpmid

The PMID for Conservative treatment of upper urinary tract carcinoma in patients with imperative indications is on the source record.

What is the OpenAlex record for Conservative treatment of upper urinary tract carcinoma in patients with imperative indications?

ScholarIQopenalex

The OpenAlex for Conservative treatment of upper urinary tract carcinoma in patients with imperative indications is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial